DE:3VG Stock Latest News
Company AnnouncementsTHX Pharma strengthens Batten-1 strategy as cash holds at €16 million1w ago
Company AnnouncementsTHX Pharma Nears Break-Even as Rare Disease Pivot Gains Traction1M ago
Company AnnouncementsTHX Pharma Secures Long-Term European Patent Protection for Batten-11M ago
Company AnnouncementsTHX Pharma Advances Batten-1 With Global Phase 3 Trial Filings for Juvenile Batten Disease2M ago
Company AnnouncementsTheranexus Reports Semi-Annual Liquidity Contract Update1y ago
Company AnnouncementsTheranexus Strengthens Cash Position and Advances Drug Development Initiatives1y ago
Company AnnouncementsTheranexus Publishes Shareholder Letter, Reinforcing Commitment to Rare Neurological Treatments1y ago
Company AnnouncementsTheranexus Strengthens Financial Outlook with New Agreements1y ago- Company AnnouncementsTheranexus Reports Promising Trial Results for Batten-11y ago
Company AnnouncementsTheranexus Updates Cash Position and Strategic Focus2y ago
Company AnnouncementsTheranexus Teams with Synerlab for Pediatric Miglustat2y ago
- Company AnnouncementsTheranexus Shows Promise in Batten Disease Study2y ago